# Novartis timeline entity: /record/novartis.md id: ent_novartis Novartis' timeline holds 59 claims from 2015 to 2025: 48 money & deals, 11 other. 11 are undated. The latest took effect on December 31, 2025. Kinds: People 0 (/timelines/novartis.md?kind=people) · Money & deals 48 (/timelines/novartis.md?kind=money) · Products 0 (/timelines/novartis.md?kind=products) · Models 0 (/timelines/novartis.md?kind=models) · Other 11 (/timelines/novartis.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2015 - 2015-12-31 to 2016-12-31 | money | total_equity | 77,122,000,000 United States dollar | superseded | [clm_F4A7EF9247D5](/claim/clm_F4A7EF9247D5.md) ## 2016 - 2016-12-31 to 2017-12-31 | money | net_income | 6,698,000,000 United States dollar | superseded | [clm_A450BC25D4EC](/claim/clm_A450BC25D4EC.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 8,268,000,000 United States dollar | superseded | [clm_EE8DEE22E155](/claim/clm_EE8DEE22E155.md) - 2016-12-31 to 2017-12-31 | money | total_equity | 74,891,000,000 United States dollar | superseded | [clm_1F7255C1F465](/claim/clm_1F7255C1F465.md) ## 2017 - 2017-12-31 to 2018-12-31 | money | net_income | 7,703,000,000 United States dollar | superseded | [clm_12A2AD908EB7](/claim/clm_12A2AD908EB7.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 8,629,000,000 United States dollar | superseded | [clm_0526738C57FA](/claim/clm_0526738C57FA.md) - 2017-12-31 to 2018-12-31 | money | total_assets | 133,079,000,000 United States dollar | superseded | [clm_2DC7A9C81128](/claim/clm_2DC7A9C81128.md) - 2017-12-31 to 2018-12-31 | money | total_equity | 74,227,000,000 United States dollar | superseded | [clm_1FFF878FB953](/claim/clm_1FFF878FB953.md) ## 2018 - 2018-12-31 to 2019-12-31 | money | net_income | 12,614,000,000 United States dollar | superseded | [clm_86476E83D754](/claim/clm_86476E83D754.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 8,169,000,000 United States dollar | superseded | [clm_D3E230AFF547](/claim/clm_D3E230AFF547.md) - 2018-12-31 to 2019-12-31 | money | shares_outstanding | 2,311,171,429 shares | superseded | [clm_35A80D4D8E81](/claim/clm_35A80D4D8E81.md) - 2018-12-31 to 2019-12-31 | money | total_assets | 145,563,000,000 United States dollar | superseded | [clm_967603AD607D](/claim/clm_967603AD607D.md) - 2018-12-31 to 2019-12-31 | money | total_equity | 78,692,000,000 United States dollar | superseded | [clm_58FF0FED75A7](/claim/clm_58FF0FED75A7.md) ## 2019 - 2019-12-31 to 2020-12-31 | money | net_income | 11,737,000,000 United States dollar | superseded | [clm_0CBFF9ABD464](/claim/clm_0CBFF9ABD464.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 9,086,000,000 United States dollar | superseded | [clm_0149AA2021B4](/claim/clm_0149AA2021B4.md) - 2019-12-31 to 2020-12-31 | money | shares_outstanding | 2,265,008,488 shares | superseded | [clm_657C4132B151](/claim/clm_657C4132B151.md) - 2019-12-31 to 2020-12-31 | money | total_assets | 118,370,000,000 United States dollar | superseded | [clm_6F1C27991C72](/claim/clm_6F1C27991C72.md) - 2019-12-31 to 2020-12-31 | money | total_equity | 55,551,000,000 United States dollar | superseded | [clm_36E9C60D9850](/claim/clm_36E9C60D9850.md) ## 2020 - 2020-12-31 to 2021-12-31 | money | net_income | 8,071,000,000 United States dollar | superseded | [clm_BEA4CCA5A4E8](/claim/clm_BEA4CCA5A4E8.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 10,152,000,000 United States dollar | superseded | [clm_ADC8AC894691](/claim/clm_ADC8AC894691.md) - 2020-12-31 to 2021-12-31 | money | shares_outstanding | 2,256,822,048 shares | superseded | [clm_FA5B2A8636EB](/claim/clm_FA5B2A8636EB.md) - 2020-12-31 to 2021-12-31 | money | total_assets | 132,059,000,000 United States dollar | superseded | [clm_4B781197482C](/claim/clm_4B781197482C.md) - 2020-12-31 to 2021-12-31 | money | total_equity | 56,666,000,000 United States dollar | superseded | [clm_0BA338FA586A](/claim/clm_0BA338FA586A.md) ## 2021 - 2021-12-31 to 2022-12-31 | money | net_income | 24,018,000,000 United States dollar | superseded | [clm_1A520E1875F6](/claim/clm_1A520E1875F6.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 11,689,000,000 United States dollar | superseded | [clm_E1378382005A](/claim/clm_E1378382005A.md) - 2021-12-31 to 2022-12-31 | money | shares_outstanding | 2,234,939,948 shares | superseded | [clm_ADE03C9FEB28](/claim/clm_ADE03C9FEB28.md) - 2021-12-31 to 2022-12-31 | money | total_assets | 131,795,000,000 United States dollar | superseded | [clm_91947C0A764E](/claim/clm_91947C0A764E.md) - 2021-12-31 to 2022-12-31 | money | total_equity | 67,822,000,000 United States dollar | superseded | [clm_70FD421198A4](/claim/clm_70FD421198A4.md) ## 2022 - 2022-12-31 to 2023-12-31 | money | net_income | 6,955,000,000 United States dollar | superseded | [clm_5646B015C0F8](/claim/clm_5646B015C0F8.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 9,197,000,000 United States dollar | superseded | [clm_9BE780A31D35](/claim/clm_9BE780A31D35.md) - 2022-12-31 to 2023-12-31 | money | shares_outstanding | 2,119,609,057 shares | superseded | [clm_009FE98CC602](/claim/clm_009FE98CC602.md) - 2022-12-31 to 2023-12-31 | money | total_assets | 117,453,000,000 United States dollar | superseded | [clm_BB5AD0135865](/claim/clm_BB5AD0135865.md) - 2022-12-31 to 2023-12-31 | money | total_equity | 59,423,000,000 United States dollar | superseded | [clm_35A920D02D20](/claim/clm_35A920D02D20.md) ## 2023 - 2023-12-31 to 2024-12-31 | money | net_income | 14,854,000,000 United States dollar | superseded | [clm_9235B12B85D4](/claim/clm_9235B12B85D4.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 9,769,000,000 United States dollar | superseded | [clm_C54C261844E4](/claim/clm_C54C261844E4.md) - 2023-12-31 to 2024-12-31 | money | shares_outstanding | 2,044,033,986 shares | superseded | [clm_0BB5090F9540](/claim/clm_0BB5090F9540.md) - 2023-12-31 to 2024-12-31 | money | total_assets | 99,945,000,000 United States dollar | superseded | [clm_E47EB2D219FD](/claim/clm_E47EB2D219FD.md) - 2023-12-31 to 2024-12-31 | money | total_equity | 46,750,000,000 United States dollar | superseded | [clm_19784DB0CE70](/claim/clm_19784DB0CE70.md) ## 2024 - 2024-12-31 to 2025-12-31 | money | net_income | 11,939,000,000 United States dollar | superseded | [clm_5BF3DA7B810B](/claim/clm_5BF3DA7B810B.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 14,544,000,000 United States dollar | superseded | [clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md) - 2024-12-31 to 2025-12-31 | money | shares_outstanding | 1,975,089,248 shares | superseded | [clm_5B7C7456996A](/claim/clm_5B7C7456996A.md) - 2024-12-31 to 2025-12-31 | money | total_assets | 102,246,000,000 United States dollar | superseded | [clm_BCE8770D5AC4](/claim/clm_BCE8770D5AC4.md) - 2024-12-31 to 2025-12-31 | money | total_equity | 44,126,000,000 United States dollar | superseded | [clm_DD45194F44A3](/claim/clm_DD45194F44A3.md) ## 2025 - 2025-12-31 | money | net_income | 13,967,000,000 United States dollar | valid | [clm_8E9D1CC51F75](/claim/clm_8E9D1CC51F75.md) - 2025-12-31 | money | operating_income | 17,644,000,000 United States dollar | valid | [clm_13AEEBEB19A6](/claim/clm_13AEEBEB19A6.md) - 2025-12-31 | money | shares_outstanding | 1,908,151,679 shares | valid | [clm_29E1C56666EB](/claim/clm_29E1C56666EB.md) - 2025-12-31 | money | total_assets | 110,949,000,000 United States dollar | valid | [clm_0705199BCCFC](/claim/clm_0705199BCCFC.md) - 2025-12-31 | money | total_equity | 46,549,000,000 United States dollar | valid | [clm_6DC4BBC10979](/claim/clm_6DC4BBC10979.md) ## undated - undated | other | cik | 0001114448 | valid | [clm_B49F45CDC592](/claim/clm_B49F45CDC592.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_CF6F00F357D4](/claim/clm_CF6F00F357D4.md) - undated | other | headquarters | Basel | valid | [clm_0F722C0A09FC](/claim/clm_0F722C0A09FC.md) - undated | other | listed_on | OTC | valid | [clm_626AF6641092](/claim/clm_626AF6641092.md) - undated | other | listed_on | NYSE | valid | [clm_A272094EA644](/claim/clm_A272094EA644.md) - undated | other | registrant_name | NOVARTIS AG | valid | [clm_9ECB34CF2487](/claim/clm_9ECB34CF2487.md) - undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_F61B5ED25295](/claim/clm_F61B5ED25295.md) - undated | other | state_of_incorporation | V8 | valid | [clm_64105409876F](/claim/clm_64105409876F.md) - undated | other | ticker | NVSEF | valid | [clm_75D99E5C33AE](/claim/clm_75D99E5C33AE.md) - undated | other | ticker | NVS | valid | [clm_FF3D83D13D18](/claim/clm_FF3D83D13D18.md) - undated | other | website | http://www.novartis.com/ | unverified | [clm_684F998583E7](/claim/clm_684F998583E7.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.